By G. Hasko, et al.,
Read or Download Adenosine Receptors - Theraputic Aspects PDF
Best nonfiction_7 books
Hardcover with airborne dirt and dust jacket
Method on chips designs have advanced from relatively uncomplicated unicore, unmarried reminiscence designs to advanced heterogeneous multicore SoC architectures including various IP blocks at the comparable silicon. to fulfill excessive computational calls for posed by way of most recent buyer digital units, most present platforms are in accordance with such paradigm, which represents a true revolution in lots of features in computing.
Designing Inclusive Futures displays the necessity to discover, in a coherent manner, the problems and practicalities that lie in the back of layout that's meant to increase our lively destiny lives. This encompasses layout for inclusion in everyday life at domestic but additionally extends to the place of work and for items inside of those contexts.
- Pioneering Venus : a planet unveiled
- Solid—Liquid Interfaces: Macroscopic Phenomena — Macroscopic Understanding
- Formal Languages and Applications
- The radiochemistry of rhenium
- Nonlinear Waves: Classical and Quantum Aspects
Additional resources for Adenosine Receptors - Theraputic Aspects
6-phenyl-1,4-dihydropyridine derivatives as potent and selective A3 adenosine receptor antagonists, J. Med. , 39, 4667, 1996. 37. Jiang, J. , Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4dihydropyridines as highly selective A3 adenosine receptor antagonists, J. Med. , 40, 2596, 1997. 38. H. , Structure-activity relationships and molecular modeling of 3, 5-diacyl2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists, J. Med. , 41, 3186, 1998. fm Page 37 Wednesday, May 24, 2006 3:00 PM Medicinal Chemistry of Adenosine A3 Receptors 37 39.
Ohno, M. , Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position, Bioorg. Med. , 12, 2995, 2004. 20. W. , 2,5′-Disubstituted adenosine derivatives: evaluation of selectivity and efficacy for the adenosine A1, A2A, and A3 receptor, J. Med. , 45, 420, 2002. 21. N. , 2-Substituted N-ethylcarboxamidoadenosine derivatives as highaffinity agonists at human A3 adenosine receptors, Naunyn-Schmiedeberg’s Arch. , 360, 103, 1999. 22. Elzein, E.
Med. , 45, 3440, 2002. 59. E. , [3H]8-Ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]-purin-5-one ([3H]PSB-11), a novel high-affinity antagonist radioligand for human A3 adenosine receptors, Bioorg. Med. Chem. , 12, 501, 2002. 60. M. , Pyrido[2,1-f]purine-2,4-dione derivatives as a novel class of highly potent human A3 adenosine receptor antagonists, J. Med. , 45, 3337, 2002. 61. G. , New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4dione derivatives as potent and selective human A3 adenosine receptor antagonists, J.
Adenosine Receptors - Theraputic Aspects by G. Hasko, et al.,